Adaptive Biotechnologies: Q2 Earnings Insights


Adaptive Biotechnologies ADPT reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.


Adaptive Biotechnologies beat estimated earnings by 13.95%, reporting an EPS of $-0.37 versus an estimate of $-0.43.

Revenue was up $5.16 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 4.32% drop in the share price the next day.

Here's a look at Adaptive Biotechnologies's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.45 -0.45 -0.42 -0.42
EPS Actual -0.44 -0.43 -0.40 -0.35
Revenue Estimate 37.71M 36.37M 36.64M 31.26M
Revenue Actual 38.62M 37.93M 39.47M 38.51M

To track all earnings releases for Adaptive Biotechnologies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!